Scientists probe Cancer's weak spot in search for better treatments
Knowledge-focused
Recruiting now
This study aims to understand how the experimental drug azenosertib affects cancer cells in women whose uterine serous carcinoma has returned or persisted after treatment. Researchers will enroll about 25 participants to take the drug and closely analyze tumor samples before and …
Phase: PHASE2 • Sponsor: Joyce Liu, MD • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC